Event
PhD Oral Defense: The M1AAP and M17LAP Aminopeptidases of Plasmodium falciparum Malaria
Monday, November 24, 2014 14:00
Parasitology Building
P-117, 21111 Lakeshore Road, St Anne de Bellevue, QC, H9X 3V9, CA
PhD Oral Defense of Rency Tesy Mathew, Institute of Parasitology
The intra-erythrocytic stage of the human malaria parasite, Plasmodium falciparum, employs two metallo-aminopeptidases, termed PfM1AAP and PfM17LAP, in the terminal stages of hemoglobin digestion. Inhibitors of these enzymes exhibit anti-malarial activity and, hence, either one or both enzymes are potential anti-malarial drug targets.